Home › Markets › Health Care › CHE

Chemed Corp (CHE)

CHE trades on NYSE in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$500.77
+0.03% on the day
Market cap
$6.5B
Mid cap
Revenue · 2025
$2.5B
+4.1% on 2024
Net income · 2025
$265K
0.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerCHE on NYSE
SectorHealth Care
IndustryMedical/Nursing Services
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000019584
SEC industry codeServices-Home Health Care Services
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.5B
Net income$265K
Operating income$338.2M
Net margin0.0%
Operating margin13.4%
Revenue growth+4.1%
Cash$74.5M
Total assets$1.5B
P/E (computed)24676.1×
P/S (computed)2.6×

Key SEC documents

DocumentFormFiled
Latest annual report
FORM 10-K
10-K2026-02-27
Latest quarterly / interim10-Q2026-07-31
Latest current report8-K2026-07-28
Latest proxyDEF 14A2026-04-06

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.3%
1 month+1.3%
3 months+2.3%
Year to date+19.9%
1 year+19.4%
From 52-week high-7.2%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Nursing Services

TickerCompanyPriceDayMarket cap
HIMSHims & Hers Health Inc.$29.71-3.04%$6.9B
LFSTLifeStance Health Group Inc.$12.32-1.28%$4.7B
OPCHOption Care Health Inc.$31.100.00%$4.7B
BTSGBrightSpring Health Services Inc.$62.65-0.57%$12.4B
PRVAPrivia Health Group Inc.$21.65+0.93%$2.8B
AVAHAveanna Healthcare Holdings Inc.$12.18-0.25%$2.7B
ADUSAddus HomeCare Corporation$114.53-0.82%$2.1B
WGSGeneDx Holdings Corp.$64.96+1.79%$1.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier